The Scottish Dementia Research Consortium, Brain Health Scotland and Alzheimer Scotland are delighted to announce the appointment of Henry McLeish as the Chair of the Scottish Brain Health and Dementia Research Strategy Oversight Board. In July 2021, the SDRC,...
On 3rd December 2021, the NHS Research Scotland Neuroprogressive and Dementia Research Network (NRS NDN) launched a new strategy. It sets out the Network’s intention to involve, engage with, and support people with lived experience of neuroprogressive...
Today (8 July 2021) sees the launch of the first Scottish Brain Health & Dementia Research Strategy. Prepared by Alzheimer Scotland, The Scottish Dementia Research Consortium and Brain Health Scotland, and endorsed by a broad range of national organisations, the...
The SDRC Annual Report 2020/21, launched at the SDRC Annual Conference 2021 on Wednesday 16th June. It outlines what research has been ongoing in dementia and brain health research in Scotland in the past 12 months. Of course, it heavily features the impact COVID has...
Aducanumab: Dr Terry Quinn explains approval of new Alzheimer’s disease drug SDRC Executive Committee member, Dr Terry Quinn, Terry takes us through all the important facts behind the recent announcement by the FDA in the US to approve aducanumab for the...
Our final announcement of new SDRC Executive Committee members is Stina Saunders. We are delighted to have Stina joining us and look forward to working with her and all the new members. Find out more about Stina in the blog below. I am in the final year of my PhD at...
